Drug Shortage Report for KADIAN
| Report ID | 3704 |
| Drug Identification Number | 02184435 |
| Brand name | KADIAN |
| Common or Proper name | Kadian |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100s |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2017-04-11 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2017-04-11 |
| Shortage status | Resolved |
| Updated date | 2017-04-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2017-04-12 | French | Compare |
| v8 | 2017-04-12 | English | Compare |
| v7 | 2017-04-12 | French | Compare |
| v6 | 2017-04-12 | English | Compare |
| v5 | 2017-04-12 | English | Compare |
| v4 | 2017-04-12 | English | Compare |
| v3 | 2017-04-12 | English | Compare |
| v2 | 2017-03-20 | French | Compare |
| v1 | 2017-03-20 | English | Compare |
Showing 1 to 9 of 9